214 related articles for article (PubMed ID: 29266188)
1. ADGRV1 is implicated in myoclonic epilepsy.
Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
[TBL] [Abstract][Full Text] [Related]
2. Electroclinical features of MEF2C haploinsufficiency-related epilepsy: A multicenter European study.
Raviglione F; Douzgou S; Scala M; Mingarelli A; D'Arrigo S; Freri E; Darra F; Giglio S; Bonaglia MC; Pantaleoni C; Mastrangelo M; Epifanio R; Elia M; Saletti V; Morlino S; Vari MS; De Liso P; Pavaine J; Spaccini L; Cattaneo E; Gardella E; Møller RS; Marchese F; Colonna C; Gandioli C; Gobbi G; Ram D; Palumbo O; Carella M; Germano M; Tonduti D; De Angelis D; Caputo D; Bergonzini P; Novara F; Zuffardi O; Verrotti A; Orsini A; Bonuccelli A; De Muto MC; Trivisano M; Vigevano F; Granata T; Bernardina BD; Tranchina A; Striano P
Seizure; 2021 May; 88():60-72. PubMed ID: 33831796
[TBL] [Abstract][Full Text] [Related]
3. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
Tonk V; Kyhm JH; Gibson CE; Wilson GN
Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
[TBL] [Abstract][Full Text] [Related]
4. MEF2C deletions and mutations versus duplications: a clinical comparison.
Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
[TBL] [Abstract][Full Text] [Related]
5. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.
Paciorkowski AR; Traylor RN; Rosenfeld JA; Hoover JM; Harris CJ; Winter S; Lacassie Y; Bialer M; Lamb AN; Schultz RA; Berry-Kravis E; Porter BE; Falk M; Venkat A; Vanzo RJ; Cohen JS; Fatemi A; Dobyns WB; Shaffer LG; Ballif BC; Marsh ED
Neurogenetics; 2013 May; 14(2):99-111. PubMed ID: 23389741
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
[TBL] [Abstract][Full Text] [Related]
7. Microdeletion 5q14.3 and anomalies of brain development.
Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
[TBL] [Abstract][Full Text] [Related]
8. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
[TBL] [Abstract][Full Text] [Related]
9. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?
Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A
Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179
[TBL] [Abstract][Full Text] [Related]
10. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.
Rocha H; Sampaio M; Rocha R; Fernandes S; Leão M
Eur J Med Genet; 2016 Sep; 59(9):478-82. PubMed ID: 27255693
[TBL] [Abstract][Full Text] [Related]
11. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
[TBL] [Abstract][Full Text] [Related]
12. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.
Carr CW; Zimmerman HH; Martin CL; Vikkula M; Byrd AC; Abdul-Rahman OA
Am J Med Genet A; 2011 Jul; 155A(7):1640-5. PubMed ID: 21626678
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide linkage of febrile seizures and epilepsy to the FEB4 locus at 5q14.3-q23.1 and no MASS1 mutation.
Deprez L; Claes LR; Claeys KG; Audenaert D; Van Dyck T; Goossens D; Van Paesschen W; Del-Favero J; Van Broeckhoven C; De Jonghe P
Hum Genet; 2006 Jan; 118(5):618-25. PubMed ID: 16273391
[TBL] [Abstract][Full Text] [Related]
14. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
15. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients.
Engels H; Wohlleber E; Zink A; Hoyer J; Ludwig KU; Brockschmidt FF; Wieczorek D; Moog U; Hellmann-Mersch B; Weber RG; Willatt L; Kreiss-Nachtsheim M; Firth HV; Rauch A
Eur J Hum Genet; 2009 Dec; 17(12):1592-9. PubMed ID: 19471318
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures.
Tang S; Addis L; Smith A; Topp SD; Pendziwiat M; Mei D; Parker A; Agrawal S; Hughes E; Lascelles K; Williams RE; Fallon P; Robinson R; Cross HJ; Hedderly T; Eltze C; Kerr T; Desurkar A; Hussain N; Kinali M; Bagnasco I; Vassallo G; Whitehouse W; Goyal S; Absoud M; ; Møller RS; Helbig I; Weber YG; Marini C; Guerrini R; Simpson MA; Pal DK
Epilepsia; 2020 May; 61(5):995-1007. PubMed ID: 32469098
[TBL] [Abstract][Full Text] [Related]
17. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype.
Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M
Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752
[TBL] [Abstract][Full Text] [Related]
18. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
19. [Genetic analysis of a case with MEF2C deletion in association with 5q14.3 microdeletion syndrome].
Zhou T; Su W; Liang D; Xu Y; Luo Y; Tong G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):779-782. PubMed ID: 34365624
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the
Guo T; Repetto GM; McDonald McGinn DM; Chung JH; Nomaru H; Campbell CL; Blonska A; Bassett AS; Chow EWC; Mlynarski EE; Swillen A; Vermeesch J; Devriendt K; Gothelf D; Carmel M; Michaelovsky E; Schneider M; Eliez S; Antonarakis SE; Coleman K; Tomita-Mitchell A; Mitchell ME; Digilio MC; Dallapiccola B; Marino B; Philip N; Busa T; Kushan-Wells L; Bearden CE; Piotrowicz M; Hawuła W; Roberts AE; Tassone F; Simon TJ; van Duin EDA; van Amelsvoort TA; Kates WR; Zackai E; Johnston HR; Cutler DJ; Agopian AJ; Goldmuntz E; Mitchell LE; Wang T; Emanuel BS; Morrow BE;
Circ Cardiovasc Genet; 2017 Oct; 10(5):e001690. PubMed ID: 29025761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]